After years of litigation and a series of legal decisions that never really gave either side any clear advantage, the battle over testosterone therapy and the methods used to market it may finally be coming to a close.
Of the nearly 7,000 lawsuits filed by men claiming that their use of testosterone therapy led to dangerous complications including heart attacks, strokes, and blood clots, more than ...
continue reading...The same judge who previously overturned a $150 million AndroGel verdict has reversed a second verdict in the litigation worth over $140 million.
The case was brought by Tennessee resident Jeffrey Konrad. Konrad alleges that his two-month period of using AbbVie’s AndroGel testosterone replacement product caused him to have a heart attack in 2010. A Chicago jury agreed and awarded him $140,000 in compensatory damages and $140 million punitively in response ...
continue reading...Yet again, a jury sent AbbVie, maker of the popular prescription testosterone drug Androgel, a loud and clear message. A federal jury in Chicago found that AbbVie misrepresented the dangers of using Androgel. And to make sure the drugmaker got their message, it also reached a verdict in excess of $140 million.
This most recent trial is the second bellwether case to be tried in the federal testosterone replacement ...
continue reading...Recent reports have raised concerns that Testosterone therapy is associated with an increased risk of heart attack, stroke, and death.
Testosterone therapy (also called androgen replacement therapy) is a growing field in pharmaceutical sales. Medications for testosterone therapy primarily take the form of pills, injections, and patches or gels that are absorbed through the skin. It is sold under brand names like AndroGel, Axiron, Fortesta, Striant, and Testim.
A study published in the ...
continue reading...
